Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129

Area of Science:

• Cardiovascular research
• Molecular biology
• Genomics and transcriptomics

Background:

• Cardiovascular disease (CVD) is a leading global cause of mortality, necessitating improved diagnostic, prognostic, and therapeutic strategies.
• The complexity of the human transcriptome and a lack of standardized data generation guidelines hinder research reproducibility and clinical translation.
• Existing research faces challenges in comparing and reproducing results due to fragmented data and limited interdisciplinary dialogue.

Purpose of the Study:

• To accelerate the understanding of cardiovascular transcriptomics.
• To translate experimental RNA data into clinical applications for personalized cardiovascular medicine.
• To establish an interdisciplinary network fostering collaboration between researchers and industry stakeholders.

Main Methods:

• Establishing a European Cooperation in Science and Technology (COST) Action network.
• Facilitating collaboration among stakeholders with complementary expertise.
• Developing consensus and guidelines for transcriptomic data generation.

Main Results:

• The initiative aims to foster rapid deciphering of RNA functions and interactions in the cardiovascular context.
• It is expected to generate innovative research projects and advance cardiovascular transcriptomics studies.
• The action seeks to consolidate European research leadership in the field of cardiovascular transcriptomics.

Conclusions:

• This COST Action will create a collaborative environment to advance cardiovascular transcriptomics.
• It aims to bridge the gap between research findings and clinical applications, enhancing personalized medicine.
• The initiative is poised to address a significant public health challenge by improving cardiovascular disease management.